» Articles » PMID: 37830576

Polyarginine Cell-Penetrating Peptides Bind and Inhibit SERCA2

Overview
Journal Cells
Publisher MDPI
Date 2023 Oct 13
PMID 37830576
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-penetrating peptides (CPPs) are short peptide sequences that have the ability to cross the cell membrane and deliver cargo. Although it is critical that CPPs accomplish this task with minimal off-target effects, such actions have in many cases not been robustly screened. We presently investigated whether the commonly used CPPs TAT and the polyarginines Arg and Arg exert off-target effects on cellular Ca homeostasis. In experiments employing myocytes and homogenates from the cardiac left ventricle or soleus muscle, we observed marked inhibition of Ca recycling into the sarcoplasmic reticulum (SR) following incubation with polyarginine CPPs. In both tissues, the rate of SR Ca leak remained unchanged, indicating that protracted Ca removal from the cytosol stemmed from inhibition of the SR Ca ATPase 2 (SERCA2). No such inhibition occurred following treatment with TAT, or in preparations from the SERCA1-expressing extensor digitorum longus muscle. Experiments in HEK cells overexpressing individual SERCA isoforms confirmed that polyarginine incubation specifically inhibited the activity of SERCA2a and 2b, but not SERCA1 or 3. The attenuation of SERCA2 activity was not dependent on the presence of phospholamban, and ELISA-based analyses rather revealed direct interaction between the polyarginines and the actuator domain of the protein. Surface plasmon resonance experiments confirmed strong binding within this region of SERCA2, and slow dissociation between the two species. Based on these observations, we urge caution when employing polyarginine CPPs. Indeed, as SERCA2 is expressed in diverse cell types, the wide-ranging consequences of SERCA2 binding and inhibition should be anticipated in both experimental and therapeutic settings.

References
1.
Roe A, Ruud M, Espe E, Manfra O, Longobardi S, Aronsen J . Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression. Cardiovasc Res. 2018; 115(4):752-764. PMC: 6432054. DOI: 10.1093/cvr/cvy257. View

2.
Skogestad J, Albert I, Hougen K, Lothe G, Lunde M, Eken O . Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure. Circulation. 2023; 147(16):1221-1236. DOI: 10.1161/CIRCULATIONAHA.121.054168. View

3.
Carlson C, Aronsen J, Bergan-Dahl A, Moutty M, Lunde M, Lunde P . AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR. Circ Res. 2021; 130(1):27-44. PMC: 9500498. DOI: 10.1161/CIRCRESAHA.120.317976. View

4.
Roe A, Frisk M, Louch W . Targeting cardiomyocyte Ca2+ homeostasis in heart failure. Curr Pharm Des. 2014; 21(4):431-48. PMC: 4475738. DOI: 10.2174/138161282104141204124129. View

5.
Suresh B, Ramakrishna S, Kim H . Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing. Methods Mol Biol. 2016; 1507:81-94. DOI: 10.1007/978-1-4939-6518-2_7. View